Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trihexyphenidyl in Childhood Hypertonia (CHOCOLATE)
NCT00122044Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Jan 2003
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trihexyphenidyl in dystonia, sponsored by University of Southern California. Primary endpoint: Melbourne Assessment of Upper Extremity Function at 15 weeks. Started Jan 2003; status: completed.
02
Drugs
trihexyphenidyl
03
Conditions
dystonia
Beyond the preview
Go deeper on NCT00122044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122044.